207 related articles for article (PubMed ID: 32154737)
1. Advances in cell-based permeability assays to screen drugs for intestinal absorption.
Volpe DA
Expert Opin Drug Discov; 2020 May; 15(5):539-549. PubMed ID: 32154737
[No Abstract] [Full Text] [Related]
2. Caco-2 cells as a model for intestinal absorption.
Angelis ID; Turco L
Curr Protoc Toxicol; 2011 Feb; Chapter 20():Unit20.6. PubMed ID: 21400683
[TBL] [Abstract][Full Text] [Related]
3. Development of an improved three-dimensional in vitro intestinal mucosa model for drug absorption evaluation.
Li N; Wang D; Sui Z; Qi X; Ji L; Wang X; Yang L
Tissue Eng Part C Methods; 2013 Sep; 19(9):708-19. PubMed ID: 23350801
[TBL] [Abstract][Full Text] [Related]
4. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.
Artursson P; Karlsson J
Biochem Biophys Res Commun; 1991 Mar; 175(3):880-5. PubMed ID: 1673839
[TBL] [Abstract][Full Text] [Related]
5. Strategies for absorption screening in drug discovery and development.
Bohets H; Annaert P; Mannens G; Van Beijsterveldt L; Anciaux K; Verboven P; Meuldermans W; Lavrijsen K
Curr Top Med Chem; 2001 Nov; 1(5):367-83. PubMed ID: 11899103
[TBL] [Abstract][Full Text] [Related]
6. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
7. Experimental models for predicting drug absorption and metabolism.
Alqahtani S; Mohamed LA; Kaddoumi A
Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1241-54. PubMed ID: 23687990
[TBL] [Abstract][Full Text] [Related]
8. Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine.
Akazawa T; Yoshida S; Ohnishi S; Kanazu T; Kawai M; Takahashi K
Drug Metab Dispos; 2018 Nov; 46(11):1497-1506. PubMed ID: 30135242
[TBL] [Abstract][Full Text] [Related]
9. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
10. Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements.
Larregieu CA; Benet LZ
AAPS J; 2013 Apr; 15(2):483-97. PubMed ID: 23344793
[TBL] [Abstract][Full Text] [Related]
11. Permeability for intestinal absorption: Caco-2 assay and related issues.
Press B; Di Grandi D
Curr Drug Metab; 2008 Nov; 9(9):893-900. PubMed ID: 18991586
[TBL] [Abstract][Full Text] [Related]
12. The in vitro intestinal cell model: different co-cultured cells create different applications.
Zou X; Liu Y; Cui M; Wan Q; Chu X
J Drug Target; 2024 Jun; 32(5):529-543. PubMed ID: 38537662
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of small intestinal permeability during normal human drug absorption.
Levitt DG
BMC Pharmacol Toxicol; 2013 Jun; 14():34. PubMed ID: 23800230
[TBL] [Abstract][Full Text] [Related]
14. Cell-based in vitro models for predicting drug permeability.
Sarmento B; Andrade F; da Silva SB; Rodrigues F; das Neves J; Ferreira D
Expert Opin Drug Metab Toxicol; 2012 May; 8(5):607-21. PubMed ID: 22424145
[TBL] [Abstract][Full Text] [Related]
15. Demonstrating suitability of the Caco-2 cell model for BCS-based biowaiver according to the recent FDA and ICH harmonised guidelines.
Jarc T; Novak M; Hevir N; Rižner TL; Kreft ME; Kristan K
J Pharm Pharmacol; 2019 Aug; 71(8):1231-1242. PubMed ID: 31155721
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs.
Antunes F; Andrade F; Araújo F; Ferreira D; Sarmento B
Eur J Pharm Biopharm; 2013 Apr; 83(3):427-35. PubMed ID: 23159710
[TBL] [Abstract][Full Text] [Related]
17. Application of a Human Intestinal Epithelial Cell Monolayer to the Prediction of Oral Drug Absorption in Humans as a Superior Alternative to the Caco-2 Cell Monolayer.
Takenaka T; Harada N; Kuze J; Chiba M; Iwao T; Matsunaga T
J Pharm Sci; 2016 Feb; 105(2):915-924. PubMed ID: 26869436
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of fasted state human intestinal fluid as apical solvent system in the Caco-2 absorption model and comparison with FaSSIF.
Wuyts B; Riethorst D; Brouwers J; Tack J; Annaert P; Augustijns P
Eur J Pharm Sci; 2015 Jan; 67():126-135. PubMed ID: 25433246
[TBL] [Abstract][Full Text] [Related]
19. The Past, Present and Future of Intestinal In Vitro Cell Systems for Drug Absorption Studies.
Youhanna S; Lauschke VM
J Pharm Sci; 2021 Jan; 110(1):50-65. PubMed ID: 32628951
[TBL] [Abstract][Full Text] [Related]
20. Validation of a Caco-2 microfluidic Chip model for predicting intestinal absorption of BCS Class I-IV drugs.
Zhang SY; Ong WSY; Subelzu N; Gleeson JP
Int J Pharm; 2024 May; 656():124089. PubMed ID: 38599444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
